Friday, 17 January 2020

Investorideas.com - Cannabis Stock News: Tetra Bio-Pharma (TSX-V: TBP) (OTCQB: TBPMF) Granted Two OTC Drug Identification Numbers (DIN) by Health Canada

Investorideas.com - Cannabis Stock News: Tetra Bio-Pharma (TSX-V: TBP) (OTCQB: TBPMF) Granted Two OTC Drug Identification Numbers (DIN) by Health Canada

Investorideas.com - Cannabis Stock News: Canopy Growth (TSX: WEED.TO) (NYSE: CGC) Revises Beverage Launch Timeline

Investorideas.com - Cannabis Stock News: Canopy Growth (TSX: WEED.TO) (NYSE: CGC) Revises Beverage Launch Timeline

Investorideas.com - Cannabis Stock News: TransCanna (CSE: TCAN) (FSE: TH8) December Revenues Increases 20% from November

Investorideas.com - Cannabis Stock News: TransCanna (CSE: TCAN) (FSE: TH8) December Revenues Increases 20% from November

www.investorideas.com - news that inspires big ideas

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Interview with Anthony Durkacz, Chairman of World Class Extractions Inc. (CSE: $PUMP.C) (OTC: $WDEXF)


Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Interview with Anthony Durkacz, Chairman of World Class Extractions Inc. (CSE: $PUMP.C) (OTC: $WDEXF)



Delta, Kelowna, BC  January 17, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:



Today’s podcast overview/transcript:

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

In today’s podcast Investorideas interviews Anthony Durkacz, the Chairman of World Class Extractions Inc. (CSE: PUMP) (OTC: WDEXF), where we discussed the company’s recent agreements in the legal Canadian cannabis market as well as the US hemp/CBD market.

Durkacz discussed some World-Class Extractions Inc. recent announcements, such as the signing of a binding Letter of Intent to establish a joint venture with Canntab Therapeutics Limited (CSE:PILL) to set-up, manage and operate a cannabis and hemp extraction and processing facility at Canntab's manufacturing center in Markham, Ontario. World-Class is entering into various joint venture agreements to deploy its systems and this agreement represents the second Canadian deployment.

The first being their multi-year joint venture agreement with FV Pharma Inc. (CSE: HUGE) (OTC: FSDDF), a wholly-owned subsidiary of FSD Pharma Inc. Under the direction of FV Pharma, World-Class will setup and manage the operations of "Cobra", a large capacity extraction and processing facility in Cobourg, Ontario, owned by FSD Pharma to extract various cannabinoids and other valuable elements from cannabis and hemp plants.

In the U.S., the company announced the signing of an agreement with Nutralife Holdings, LLC and Nutralife Extraction Limited Partnership to establish a joint venture to develop, manage and operate a hemp extraction and processing facility in Imperial County, California to extract hemp oil from hemp biomass in compliance with the U.S. Agriculture Improvement Act of 2018 – also known as the Farm Bill.

When asked what separates World Class Extractions from the heavy competition in the extraction space, Durkacz commented, “our extractors are designed and built with our technology. So this is not off the shelf equipment that you’re buying from China or from other areas. This is developed by us. We use proprietary equipment which is patent pending, that we’ve invented. We believe that our equipment provides higher efficiency, so overall it should reduce cost. The other aspect to extraction is quality. So very much like the flower market today whether you’re dealing with hemp or cannabis, quality is key. You have to have quality and price to be a leader today and that’s what we’re able to do.”

Durkacz then went on to discuss in more detail how these recent agreements will continue to add value to World Class Extractions as well as how the hemp and cannabis industries are expected to evolve and what companies can do to properly evolve with it.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy  policy:

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.


Follow us on Cannabis Social Media
Download our Mobile App for iPhone and Android  

Contact Investorideas.com
800-665-0411







Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory



Thursday, 16 January 2020

Investorideas.com - Learn More About What's Causing the Purple Haze Over Arizona

Investorideas.com - Learn More About What's Causing the Purple Haze Over Arizona

Investorideas.com - Cannabis Stock News: Aphria Inc. (TSX: APHA) (NYSE: $APHA) Launches Plant Positivity Immersive Winter Garden to Help Combat Winter Blues

Investorideas.com - Cannabis Stock News: Aphria Inc. (TSX: APHA) (NYSE: $APHA) Launches Plant Positivity Immersive Winter Garden to Help Combat Winter Blues

Investorideas.com - Cannabis Stock News: Liberty Health Sciences (CSE: LHS) (OTCQX: LHSIF) Expands Operations in the New Year; Opens its 23rd Dispensary in Lakeland, FL.

Investorideas.com - Cannabis Stock News: Liberty Health Sciences (CSE: LHS) (OTCQX: LHSIF) Expands Operations in the New Year; Opens its 23rd Dispensary in Lakeland, FL.

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; (CSE: $DIXI_U.C) (OTCQX: $DXBRF) (CSE: $AUSA.C) (CSE: $BEV.C)


Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; (CSE: $DIXI_U.C) (OTCQX: $DXBRF) (CSE: $AUSA.C) (CSE: $BEV.C)



Delta, Kelowna, BC, January 16, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

Read this in full at


Today’s podcast overview/transcript:

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

In today’s podcast we look at a few early announcements.

But first, The Medical Cannabis Clinics, recently CQC registered, is the UK's largest and fastest growing chain of private cannabis clinics, with doctors now operating from seven locations across the country and more openings planned over the coming months to meet patient demand.

Through working in collaboration with the global leaders in medical cannabis education and training, The Academy of Medical Cannabis, the clinic chain has amassed a team of skilled clinicians who have been trained to prescribe cannabis-based medicine.

The demand for cannabinoid medicine has never been more evident after this week's release of a YouGov poll suggesting a staggering 1.4 million British citizens are resorting to using cannabis illegally in an attempt to treat a range of conditions and symptoms.

According to Jonathan Nadler, Group MD at LYPHE Group: "Patients should be able to access legal medical cannabis but both advocates and doctors have been thoroughly dissatisfied with the lack of progress since cannabis was rescheduled in 2018. Many were outraged when NICE issued their latest recommendations a couple of months ago in which only two cannabis-based drugs, Epidyolex and Sativex, were recommended for use by those suffering from either rare forms of childhood-onset epilepsy or spasticity related to multiple sclerosis. This update left many, including patients suffering from other conditions like fibromyalgia and chronic pain, feeling snubbed by the healthcare institute and the medical community as a whole. NICE's guidance is often taken as gospel by healthcare professionals who won't prescribe without its explicit authorisation."

However the NICE guidance does not override the responsibility of healthcare professionals to carefully assess and assign the appropriate line of treatment in their patients' best interests. So, through asserting the right to their own clinical discretion around their patient's treatment and care, specialists are now taking back their power to prescribe, providing high quality and effective medical cannabis care in the process.

The guidelines specifically state: 'Once NICE guidance is published, health professionals are expected to take it fully into account when exercising their clinical judgement. However, NICE guidance does not override the individual responsibility of health professionals to make appropriate decisions according to the circumstances of the individual patient in consultation with the patient and / or their guardian or carer.'

Jonathan Nadler added: "Doctors operating with The Medical Cannabis Clinics are not afraid to exercise their knowledge and expertise to write medical cannabis prescriptions for patients who need it. With clinics in London (Harley Street), Birmingham (Solihull), Manchester, Nottingham, Leeds, Newcastle and Bristol, we are proud to be assisting patients across the country."


Dixie Brands Inc. (CSE: DIXI.U) (OTCQX: DXBRF), one of the cannabis industry's leading consumer packaged goods ("CPG") companies, confirmed that, in conjunction with its manufacturer, it will launch Dixie's initial  branded product offering into the Oklahoma medical cannabis market by the end of January 2020, meeting its expectation announced in the previous press release related to the Oklahoma expansion. The initial offering will be followed by a full portfolio launch, including Dixie's pioneering CBD brand AcesoHemp, in February 2020.

Dixie, a pioneer in the development of infused-cannabis products since 2010, has built one of the industry's most comprehensive portfolios via a deep R&D and production heritage built over nearly a decade. With over 100 products across more than 15 different product categories, the portfolio represents one of the industry's most extensive 'House of Brands' encompassing both regulated THC and ratio brands in Dixie and Synergy and hemp-derived CBD offerings, including AcesoHemp and Therabis.

Oklahoma is one of the country's fastest growing legal cannabis markets with over 200,000 registered patients driving more than $250 million in regulated retail sales as of October 2019 (source: KUTL, December 4th, 2019). With more than 5% of the state's population now registered as medical cannabis patients, exceeding any other program in the nation, the category was expected to eclipse $350 million by the end of 2019 (Source: Marijuana Business Daily, November 19, 2019). The passing of SQ788 (the bill legalizing cannabis for medical use) provides the opportunity for licensed dispensaries to offer patients both THC and hemp-derived CBD products.

"We are excited to be bringing Dixie's unparalleled portfolio of THC & CBD-infused brands to 200,000 medical patients in the dynamic Oklahoma market" said Chuck Smith, President and CEO, Dixie Brands. "The fact that we are able to bring product to market within 60 days of announcing our licensed manufacturing partner is a testament to the agility and expertise the Dixie Brands team has developed over a decade in business".

The growth of Oklahoma's medical cannabis market to date has been far greater than any other medical market launch. 2019 saw medical patient counts increase eightfold and over 2,000 dispensary licences issued (Source: Marijuana Business Daily, November 19, 2019), providing an exciting early mover opportunity for Dixie's well-established portfolio of brands in this rapidly growing market.

Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) announced that AUSA's wholly-owned brands Tsunami™, a science-driven recreational extract brand, and GT Flowers, continue to receive industry recognition as leaders in product innovation and quality with wins at the High Times Cannabis Cup Nevada 2019 in a rare four-category sweep: 1st Place Best Indica Concentrates, 1st Place Best Sativa Concentrates, 2nd Place Best Hybrid Concentrates, and 3rd Place Vape Cartridges. As the premier competition in the cannabis industry, the High Times Cannabis Cup spotlights top companies and products in the Nevada cannabis market.

"The great showing at the High Times Cup validates the hard work, creativity and care Green Therapeutics uses when approaching the cultivation and extraction processes," said Dr. Duke Fu, CEO of Green Therapeutics, LLC. "We are proud to have been successful in the manufacturing and creation of differentiated products that bring joy to our customers."

As the cannabis industry continues expanding, consumers are seeking premium-quality cannabis options from quality suppliers. Tsunami™, Provisions™, and GT Flowers answer this demand with high-quality, innovative products, a wide array of phenotypes, and broad distribution through some of the largest dispensaries in Nevada, including Planet 13, The Source, and THRIVE Marketplace. GT Flowers is exclusively sold through The Source and in 2019, Tsunami™ became the exclusive premium extract provider to the only consumption lounge in Nevada.

"These wins along with the growth of AUSA's brands in Nevada prove that marijuana brands built on quality cultivation, extraction, marketing, and management will thrive and grow with the consumer," said Cleve Tzung, SVP of Mergers & Acquisitions at AUSA. "We're very proud of the GT team that was acquired less than a year ago and look forward to introducing our award-winning brands to new markets in the coming months."

Tsunami™, Provisions™, and GT Flowers continue to increase sales, focusing on high turnover SKUs to supply the high volume demands from some of the largest dispensaries in Nevada, while expanding and developing new dispensary partnerships.

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB:BVNNF) announced that it has acquired Carmanah Craft Corp.

Pursuant to a share exchange agreement dated January 13, 2020 with Carmanah and each of the shareholders of Carmanah, the Company has completed the acquisition of all the issued and outstanding securities of Carmanah and the business of Carmanah.

The acquisition of the cannabis genetics expert gives BevCanna access to an extensive library of cannabis genetics, including 50 premium cannabis strains and over 25 types of cannabis seeds, including six auto flower seed varieties. There is an excess of 50 strains by clone and 250,000 cannabis seeds ranging from high THC to high CBD. Additionally, a large portion of the genetics are outdoor-specific strains that originated in California, which boasts a very similar climatic zone to our operations in the Okanagan and are expected to increase yields. The library of genetics includes many of the top mold resistant, outdoor, high yielding, auto flower seeds, many of which are anticipated at 2kg+ of yield per plant. With the addition of such a substantial auto flower library, the harvest times will start much earlier allowing for much more organized final processing.

"This deal will dramatically increase our overall cannabis yield projections." said Joey Bedard-Brunet, Head of Cultivation at BevCanna. "Together with the recently announced increase in our outdoor cannabis cultivable land to almost 300 acres, the acquisition of Carmanah's proven outdoor genetics will allow BevCanna to develop into one of the largest outdoor cannabis cultivators in Canada." said John Campbell, Chief Strategy Officer at BevCanna.

One World Pharma, Inc. (OTCQB: OWPC), a fully licensed pure-play cannabis and hemp ingredient producer in Colombia, has been honored by the Assembly of the Department of Cauca, Colombia for its efforts to invest in, develop and empower the local population in the region. The award is the highest distinction granted by the Assembly, and was approved unanimously by the governing body.
One World Pharma’s mission is to create a leading international cannabis and hemp ingredient company which leverages the extremely beneficial natural conditions in equatorial Colombia with the best interests of the indigenous people in mind. To that end, OWP has put the people of the once troubled State of Cauca first; hiring, training, and partnering hand-in-hand with them in a shared goal to capitalize on the unique Colombian cannabis and hemp opportunity.

The company has already hired a large number of indigenous people and created new opportunities for them to partner in profitable outcomes. In addition, One World Pharma has overseen the construction of new roads, running water and other essential amenities.

“We are proud to walk-the-walk and not just talk-the-talk,” stated Brian Moore, President, One World Pharma.  “Our company was and is intent on a business model that lifts others up, changes their lives for the better, and harnesses that goodwill as the driving force to become a real agent of change in Colombia and the international cannabis and hemp marketplace. This award, given by those who know us best, is a testament to our commitment and to the life-changing impact of our devoted team.”

“This is more than just an honor from our friends and partners for a new Colombia,” stated Moore. “It is an affirmation of our pledge to work in partnership with the people who need it most, and to collaborate in this emerging part of Colombia to benefit their people.”

“As we draw ever closer to our first harvests and revenue generating activities, it is heartening to have our core humanitarian mission acknowledged,” added Moore. “The people of Cauca are now closer to living the lives every human deserves.”

Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info:
https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire
https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.


Follow us on Cannabis Social Media
Download our Mobile App for iPhone and Android  

Contact Investorideas.com
800-665-0411

  



Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory

Tuesday, 14 January 2020

Investorideas.com - New Approach Montana Submits 2020 Marijuana Legalization Ballot Initiatives for State Review

Investorideas.com - New Approach Montana Submits 2020 Marijuana Legalization Ballot Initiatives for State Review

Investorideas.com - Cannabis Stock News: Aphria Inc. (TSX: APHA) (NYSE: APHA) Announces Third Consecutive Quarter of Positive Adjusted EBITDA and a 46% Increase in Adult-Use Cannabis Revenue From Prior Quarter

Investorideas.com - Cannabis Stock News: Aphria Inc. (TSX: APHA) (NYSE: APHA) Announces Third Consecutive Quarter of Positive Adjusted EBITDA and a 46% Increase in Adult-Use Cannabis Revenue From Prior Quarter

Investorideas.com - YIELD GROWTH (CSE: BOSS) (OTCQB: BOSQF) Subsidiary Flourish Mushroom Labs Appoints Neurologist and Psychiatrist Dr. William Panenka as Chair of the Medical Advisory Board

Investorideas.com - YIELD GROWTH (CSE: BOSS) (OTCQB: BOSQF) Subsidiary Flourish Mushroom Labs Appoints Neurologist and Psychiatrist Dr. William Panenka as Chair of the Medical Advisory Board

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; (TSX: $FAF.TO) (TSXV: $N.V) (TSXV: $KHRN.V) (TSX: $APHA.TO) (NYSE: $APHA)


Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; (TSX: $FAF.TO) (TSXV: $N.V) (TSXV: $KHRN.V) (TSX: $APHA.TO) (NYSE: $APHA)



Delta, Kelowna, BC, January 14, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:



Today’s podcast overview/transcript:

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

In today’s we look at a few early announcements.

But first, Purpose Investments Inc.  launched the Medical Cannabis & Wellness UCITS ETF, representing Purpose’s first offering in the European market. The Fund is being made available through Purpose’s partnership with HANetf, an independent European ETF specialist backed by renowned investor Steve Cohen’s Point72 Ventures.
The first of its kind for European investors, the Fund listed earlier today on the Deutsche Boerse XETRA exchange in Germany. It will be listed on the London Stock Exchange in the UK and the Borsa Italiana in Italy later this month.
“The medical cannabis industry was pioneered in Canada, and we’re thrilled with the opportunity to partner with HANetf to take what we have learned from our Purpose Marijuana Opportunities Fund (MJJ) to Europe. We believe that the cannabis sector is still in the infancy stages of a multi-year growth phase and that there is ample opportunity for innovation and new discoveries. We are very excited to embark on this journey with HANetf in a global investor market,” said Som Seif, CEO and founder of Purpose Investments.
The Fund offers European investors unique exposure to the global medical cannabis market and the CBD wellness sector. Additionally, the Fund invests in ancillary services that support companies within the medical cannabis and CBD categories.
“Up until now, European investors have experienced restricted access to the cannabis market. With the launch of this truly innovative ETF, there is now a product for investors who want exposure to the cannabis industry through a pre-screened basket of Cannabis securities and in a regulated UCITS ETF. Due to the operational and legal due diligence that has gone into developing this truly innovative ETF, investors can readily access an investment vehicle which can significantly reduce their legal risk versus investing directly in single cannabis securities. It is also is a great way to diversify as investors don’t need to research each individual security and the ETF may help to withstand the short-term volatility of individual securities, potentially making for a lower risk, longer-term investment,” said Hector McNeil, co-Founder and co-CEO of HANetf.

Fire & Flower Holdings Corp. (TSX: FAF) and its wholly-owned subsidiary Fire & Flower Inc., announced that it has achieved the milestone of 45 open and operating cannabis retail stores.

Fire & Flower has previously stated that the Company anticipated achieving the milestone of 45 retail cannabis stores by the end of its fiscal year, being February 1, 2020. The Company has achieved this milestone several weeks in advance of its previously stated goal and today has 46 open and operating stores across its retail network.
  
The new stores included in the Company's milestone achievement are located at the following addresses:
  
     1108 4th street SW, Calgary, Alberta
     6004 Country Hills Blvd NE, Calgary, Alberta
     212, 11245 Valley Ridge Drive NW, Calgary, Alberta
     350, 590 Baseline Road, Sherwood Park, Alberta
     19-99 Wye Road, Sherwood Park, Alberta
     1276 3 Avenue South, Lethbridge, Alberta
     10 Westwind Drive, Spruce Grove, Alberta
     40 Hewlett Park Landing, Sylvan Lake, Alberta
     4331-52 Avenue, Whitecourt, Alberta

"Fire & Flower is committed to delivering on the targets that we have provided to our shareholders and reaching 45 cannabis retail stores several weeks in advance of when we had anticipated to reach this target is a clear demonstration of our discipline in achieving our goals," shared Trevor Fencott, Fire & Flower's Chief Executive Officer. "Achieving this aggressive goal is a testament to our deep retail experience and strong management team. As the cannabis industry continues to face headwinds, Fire & Flower is well positioned to continue to achieve growth and demonstrate leadership in the category."

The Company continues to focus on opening new retail stores across Alberta, where the AGLC continues to issue retail licences, and in the province of Ontario where open licensing has commenced. Fire & Flower is also closely monitoring regulatory environments and taking proactive steps in provinces across Canada to ensure early market entry when private retail opportunities emerge.

Namaste Technologies Inc. (TSXV: N) (OTC: NXTTF), a leading online platform for cannabis products, accessories, and responsible education today announced that Choklat Inc., an Alberta-based craft chocolate manufacturer and chocolatier in which Namaste holds a 49% equity position, has received a processing license from Health Canada to produce a line of chocolate bars, drink mixes and infused sugar.

"Receiving the processing license from Health Canada is a significant achievement and milestone," said Brad Churchill, CEO of Choklat. "We look forward to introducing our cannabis infused product line, products with a pure chocolatey taste with no aftertaste, across Canada leveraging the extensive B2B sales channels that CannMart Inc. has built. Our high-quality cannabis infused bars and beverages will be based on our own chocolate recipe made from a special cocoa bean sourced from the jungles of South America. This is an exciting time for Choklat, CannMart and Namaste as we enter the competitive cannabis 2.0 landscape."

"Brad Churchill is a true pioneer when it comes to the actual production of chocolate, and he is now applying his extensive experience and passion to produce high quality cannabis-infused chocolates," said Meni Morim, Chief Executive Officer at Namaste Technologies Inc. "We believe there is pent up demand for cannabis-infused edible products on a national scale. Choklat is one of the first food processors in Canada to receive its processing license from Health Canada and we expect their products to be on shelves in March, allowing for the Health Canada notice period. We invested in Choklat not only to maximize the significant market opportunity for cannabis-infused edibles but also because we see Brad as a true craftsman in his trade and the quality of his products speak for themselves."

The Cannabis Regulations require licenced processors to submit a notification to Health Canada of their intent to sell each novel cannabis product in Canada at least 60 calendar days before making such cannabis products available for sale. CannMart will be submitting up to 11 unique product SKUs to Health Canada for the new derivative product formats that the Company intends to offer for sale beginning in March. New products are expected to include dark, white and milk chocolate bars, chocolate-based beverages and infused sugar, that have been formulated, developed and packaged to meet the regulatory requirements set out by Health Canada. These new product formats will be added to Namaste's e-commerce website CannMart.com and offered through provincial cannabis stores in authorized markets.

What sets Choklat apart from other chocolatiers is that Choklat imports premium cocoa beans in the world, then roasts, grinds and refines them on-site into chocolate that meets exacting taste specifications. Creating the chocolate allows for complete control over the quality and taste of the final products which Namaste and Choklat believe provides an advantage over competitors. Namaste, CannMart and Choklat are all about treating customers with respect and integrity and using only the highest quality products and natural ingredients.

Choklat has existing sales of non-infused products through both its online e-commerce site and a network of distributors across Canada. The chocolate manufacturer has experienced significant expansion while preparing for the legalization of edibles and has non-infused products available in over 150 retail outlets across Canada, including an increasing number of Safeway and Sobeys stores in Western Canada. Choklat has also applied for and received its FDA number for the sale of  non-infused chocolate bars in the United States.

Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQB: KHRNF), a vertically integrated cannabis leader with core operations in Latin America,announced the opening of Zerenia, a fully integrated medical care clinic designed to meet patient health and well-being. Operating in a 15,000 sq. ft facility in Bogota's prime medical services district, the clinic increases Khiron's clinical capacity by 75% and forms part of the Company's patient acquisition strategy as it prepares for the issue of cannabis prescription in Colombia.

Zerenia offers a person-centered integrated care model, with the concept of integrative medicine combining traditional and complementary medicine, and with evidence-based treatments and high professional practices. Services are delivered across multiple clinical units include: Pain management, mental health, surgical, neurology and dentistry, supported by rehabilitation, complementary medicine and diagnostic technology, involving programs for managing multiple symptoms in different pathologies. Prominently located in Bogota's city centre, Zerenia builds on the integration and growth of the Company's wholly-owned Ilans neurological clinics and its over 60 physicians, and is staffed by a team of health professionals and clinical leaders representing different specialties.
  
Phase one of the 15,000 sq. ft clinic is open for treatments and phase two will be ready to receive patients in March 2020.
  
"We are excited to be opening Zerenia in Bogota, a busy city of more than 10 million people and a population increasingly demanding convenient, one-stop access to medical care of the highest professional standards. In a state of the art clinic, our physicians and health care professionals will consult with patients and offer appropriate treatment therapies."  Comments Martha Edith Oyuela, Khiron Health Vice President. "For the first time patients will have access to an array of integrated professional, patient-centred options."

"Our strategy in launching Zerenia is to meet a very clear market need to treat the whole patient in one professional environment. With the success of our Ilans clinics, and the growing movement towards integrated medical care, we are leading the market in bringing this concept to Colombia. This strategy further expands our reach to bring patients into the Khiron network, including those that are well suited for cannabis therapies." Adds Khiron CEO and Director Alvaro Torres.

Aphria Inc. (TSX: APHA) (NYSE: APHA) reported its results for the second quarter ended November 30, 2019. All amounts are expressed in thousands of Canadian dollars, unless otherwise noted and except for per gram, kilogram, kilogram equivalents, and per share amounts. The Company also announced that Irwin D. Simon, will officially remove "interim" from his title, effective today. In addition to his responsibilities as Aphria's Chairman of the Board, Mr. Simon had been serving as Interim Chief Executive Officer since February 2019.

"We are very pleased with our strong growth and execution in Canada demonstrated by our increase in adult-use cannabis revenue and positive adjusted EBITDA as a result of our compelling brands and market positioning," stated Irwin D. Simon, Chairman and Chief Executive Officer. "We are continuing to expand our capabilities internationally with solid progress during the quarter in Germany and South America and look to monetize non-core assets. We are confident in our market position and our ability to generate sustainable profit growth. I am honoured to continue to work closely with our tremendous team around the world to fuel growth and value for all of our stakeholders. Going forward, we believe our brands, cultivation expertise, cash position and balance sheet will continue to differentiate us in the cannabis industry, and we remain focused on the highest return opportunities for growth."

Some of the key Operating Highlights included, a revenue for adult-use cannabis of $29.0 million in the second quarter, an increase of 46% from prior quarter, a net cannabis revenue of $33.7 million in the second quarter, an increase of 9% from prior quarter and a net revenue of $120.6 million in the second quarter, an increase of 457% from prior year quarter and decrease of 4% from prior quarter.

Aphria was also recognized for seven awards at the 6th Annual Canadian Cannabis Awards with all five of Aphria's medical and recreational brands receiving awards, as well as Broken Coast's Master Grower, Kevin Anderson, winning 'Master Grower' accolades and Aphria's Solei's CBN Renew oil 'Innovation of the Year'.

Carl Merton, Aphria's Chief Financial Officer commented, "We are updating our annual outlook with a little over four months left in our fiscal year to reflect certain market dynamics that have evolved relative to our initial expectations.  We look forward to generating an acceleration in our revenue and profit growth in the second half of the fiscal year and continue to believe the Canadian and international cannabis industry outlook remains robust. Aphria is well positioned for long-term sustainable growth as we continue to manage the controllable aspects of our business."

Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.


Follow us on Cannabis Social Media
Download our Mobile App for iPhone and Android  

Contact Investorideas.com
800-665-0411

  


Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory

Investorideas.com - Cannabis Stock News: Tetra Bio-Pharma (TSX-V: TBP) (OTCQB: TBPMF) Granted Two OTC Drug Identification Numbers (DIN) by Health Canada

Investorideas.com - Cannabis Stock News: Tetra Bio-Pharma (TSX-V: TBP) (OTCQB: TBPMF) Granted Two OTC Drug Identification Numbers (DIN) by H...